01-04-2019 07:29 AM CET - Health & Medicine

Extensive Drug Development and Clinical Research Activities to Drive Clinical Trial Management System Market

Press release from: Knowledge Sourcing Intelligence LLP

The report published by Knowledge Sourcing Intelligence titled “Global Clinical Trial Management System (CTMS) - Forecast From 2018 to 2023” studies the various factors affecting the market for antibody drug conjugates. The report has been segmented by Type (Enterprise CTMS and Site CTMS), by Deployment Model (Cloud-based and On-Premise CTMS), by Component (Services, Hardware, and Software) and by End Users (Pharmaceutical and Biopharmaceutical Companies, Other Healthcare Providers and CROs).

In addition, the market for a CTMS has been estimated based on the geography, covering five regions namely North America, South America, Europe, Middle East and Africa and the Asia Pacific, and some of the major economies in each of these regions. The demand for CTMS would primarily be driven on account of the rising number of drug development and clinical research activities. Rising demand of the CTMS to reduce the cost and administrative burden of the clinical will also boost the adoption of CTMS, thus, having a positive impact on the market across the globe. However, issues related to the data security coupled with the high cost of CTMS might hinder the growth of the market during the given time frame.

Request sample: www.knowledge-sourcing.com/requestsample&sample_id=2181

By component, the hardware is projected to hold significant market share in the global CTMS market in 2018.

It is estimated that the hardware segment holds a significant share in 2018 and will grow at a modest rate owing to the technological innovations in hardware and rising use of tablets and iPads which have allowed for greater flexibility to clinical research teams and ability to access the data from remote location, thus providing users with a more intuitive and efficient way of working.
The North America region is estimated to dominate the market throughout the forecast period.

The demand for CTMS was comparatively high in the North America region owing to the number of clinical research activities in the region coupled with favorable government initiatives. Asia – Pacific is expected to grow at a robust CAGR owing to the presence of CROs in the region supporting foreign players to conduct clinical trials thus, accelerating the demand for clinical trial management solutions in the future.

This report also includes a study of strategies and product portfolios of some of the leading companies in the global electric capacitor market. It consists of company profiles of the leading companies such as Parexel International Corporation, Breeze CTMS, and Business Systems Integration AG among others.

Request customization or place your order: www.knowledge-sourcing.com/global-clinical-trial-manageme...

About Us:
Knowledge Sourcing Intelligence (KSI) is a market research and consulting organization based out of India. KSI publishes research studies spanning across ten industry verticals. KSI has a team of experienced and young professionals with a singular focus on delivering high-quality research services to enterprises, non-government organizations, government agencies, and research institutes and organizations. We publish hundreds of reports per year centering on niche and latest technologies. We engage with key decision makers and stakeholders across the value chain to provide clients with a detailed analysis and bird’s-eye view of the market with whole market dynamics, statistical forecasts, competitive analysis, key trends, market drivers and challenges and strategic recommendations for making informed decisions. Our success lies in the effort of our analysts who strive to meet client expectations by delivering quality work within the stipulated deadlines.

Contact Us:
Knowledge Sourcing Intelligence LLP
2nd Floor, D-77, Sector 63
Noida, U.P. - 201301

This release was published on openPR.
News-ID: 1470325 • Views: 175
More releasesMore releases

You can edit or delete your press release here: